Ceramides for Skin: What They Are, How They Work & Why Your Barrier Needs Them | Boldpurity
Effects described are based on cosmetic use and published research. Results may vary depending on formulation, concentration, and individual skin type.
If you are searching for what ceramides are, why ceramides deplete, whether ceramides are better than hyaluronic acid, or how to use ceramides in a skincare routine — this guide covers the complete science, from lamellar bilayer architecture to topical formulation evidence.
Ceramides are sphingolipid molecules that make up approximately 50% of the intercellular lipid matrix in the stratum corneum. They organise into lamellar bilayer structures between skin cells — forming the structural "mortar" that governs transepidermal water loss and barrier resilience. Ceramide levels are associated with declining with age and environmental stress; published research documents that topical ceramide formulations support barrier integrity and are associated with measurable improvements in TEWL and hydration markers.
- Ceramides are the dominant lipid class in the stratum corneum — not a trend ingredient but a structural component the skin produces naturally and depends on.
- They organise into lamellar bilayer structures between corneocytes — the physical architecture that regulates moisture loss and determines how resilient your barrier is.
- Published research documents their depletion in association with ageing, harsh surfactants, UV exposure, and skin associated with barrier impairment.
- Topical ceramides — particularly formulated alongside complementary cholesterol and free fatty acids — are documented for association with improved TEWL and hydration markers in studied populations.
- Ceramides are not associated with pore congestion in published assessments and are generally well-tolerated across skin types in the reviewed literature.
- One of the most clinically supported ceramide delivery approaches is ratio-based: ceramides alone are less effective than ceramides formulated in a system with cholesterol and fatty acids.
- What are ceramides — and why are they different from other moisturising ingredients?
- How ceramides work: the barrier mechanism
- The different types of ceramides — all 12 subclasses, pseudo-ceramides & label reading
- Why ceramide levels fall — depletion triggers
- Ceramide benefits for skin
- Can ceramides support skin barrier function?
- Ceramides by skin type
- Ceramides vs other barrier ingredients
- How to use ceramides in a skincare routine
- What to combine ceramides with
- Side effects of ceramides — are they safe?
- Frequently asked questions
Ceramides occupy a unique position in skincare science. Unlike most active ingredients — which are added to do something the skin cannot do for itself — ceramides are ingredients the skin already produces, relies on, and depletes over time. Understanding them means understanding the fundamental architecture of the skin barrier itself.
The clinical interest in topical ceramides is not driven by trend. It is driven by decades of barrier biology research — from the foundational work of Dr Peter Elias and colleagues on stratum corneum lipid organisation in the 1970s and 1980s, to contemporary randomised controlled trials measuring TEWL outcomes in studied populations with barrier impairment. The science is among the most mature in cosmetic dermatology.
What Are Ceramides — and Why Are They Different From Other Moisturising Ingredients?
Ceramides are a class of lipid molecules belonging to the sphingolipid family. Structurally, each ceramide consists of a fatty acid chain linked via an amide bond to a sphingoid long-chain base — typically sphingosine, phytosphingosine, 6-hydroxysphingosine, or dihydrosphingosine. This molecular architecture is what defines the ceramide class and differentiates it from other skin lipids.
What makes ceramides distinct from most moisturising ingredients is where they work and what they do. Humectants like hyaluronic acid attract water. Occlusives like petroleum jelly seal the surface. Ceramides do neither of these things primarily. Their function is structural: they organise into the intercellular lipid matrix that physically governs how much water escapes through the skin — and how well the skin resists external irritants.
In quantitative terms, ceramides constitute approximately 50% of the intercellular lipid matrix by weight in healthy stratum corneum, with cholesterol (~25%) and free fatty acids (~15%) accounting for most of the remainder. This specific lipid ratio — maintained in healthy skin — is associated with the formation of functional lamellar membrane structures. Alteration of this ratio, through ceramide depletion or the absence of complementary lipids, is documented in published research as associated with compromised barrier function and increased transepidermal water loss.
The central role of ceramides in barrier function was not established until the landmark structural studies of Dr Peter Elias (UCSF) in the late 1970s and 1980s. His "brick-and-mortar" model — corneocytes as bricks, the intercellular lipid matrix as mortar — remains the foundational framework in barrier biology to this day. Prior to this work, the stratum corneum was widely considered a passive, inert layer.
How Ceramides Work: The Barrier Mechanism
The barrier function of ceramides is structural, not biochemical. To understand it, the brick-and-mortar model is the starting point — but the mechanism is more precise than the analogy suggests.
The lamellar body pathway. In the stratum granulosum — the layer just beneath the stratum corneum — keratinocytes contain specialised organelles called lamellar bodies (Odland bodies). These package lipid precursors including glucosylceramides, sphingomyelin, phospholipids, and cholesterol into organised lamellar sheets. As keratinocytes complete terminal differentiation and transition into corneocytes, lamellar bodies fuse with the cell membrane and extrude their contents into the intercellular space.
Enzymatic conversion to mature ceramides. Once in the intercellular space, enzymatic processing converts lipid precursors into mature ceramide subclasses. Glucocerebrosidase converts glucosylceramides to ceramides; sphingomyelinase converts sphingomyelin; secreted phospholipase A2 processes phospholipids to fatty acids. The result is the ceramide-rich intercellular matrix.
Lamellar bilayer organisation. Mature ceramides self-organise into densely packed lamellar bilayer sheets within the intercellular space. These sheets — alternating hydrophilic headgroups and hydrophobic fatty acid chains — form the physical structure that regulates water diffusion across the stratum corneum. Electron microscopy of healthy stratum corneum reveals characteristic alternating broad-narrow-broad lamellar band patterns. In skin associated with barrier impairment, these patterns are disrupted or absent in the corresponding regions.
Ceramide NP, NS, and AP (filled circles) occupy single bilayer planes — their hydrophilic headgroups face the bilayer line and hydrophobic tails interdigitate. Ceramide EOP (open circle → dashed line) extends from one bilayer to the next — its linoleic acid ester chain physically links adjacent lamellar units. TEWL is regulated by the integrity of this entire multi-bilayer stack.
Corneocytes (bricks) — protein-filled, terminally differentiated skin cells — are embedded in the intercellular lipid matrix (mortar), of which ceramides form ~50% by weight. This matrix is not a homogeneous oil. It is a precision-organised system of lamellar bilayers that physically restricts transepidermal water loss and the ingress of irritants. The structural integrity of this system is what we mean when we talk about "skin barrier function."
The critically important role of Ceramide EOP (formerly Ceramide 1) in this architecture is its unique ω-hydroxy fatty acid esterified to linoleic acid — a chain long enough to span and link adjacent lamellar bilayers. This bridging function plays a uniquely important structural role; reduced Ceramide EOP levels are associated with disrupted lamellar organisation in ways that shorter-chain ceramides cannot compensate for.
The Different Types of Ceramides in Skincare
Twelve ceramide subclasses have been characterised in human stratum corneum, classified by two structural variables: the fatty acid headgroup (N = non-hydroxy, A = alpha-hydroxy, O = ω-hydroxy, E = esterified ω-hydroxy) and the sphingoid base (S = sphingosine, H = 6-hydroxysphingosine, P = phytosphingosine, D = dihydrosphingosine). The INCI nomenclature adopted this system to replace an older numerical classification (Ceramide 1, 2, 3, etc.).
The sphingoid base and fatty acid headgroup each contribute one or two letters to the INCI name. All 12 ceramide subclasses arise from combinations of these two structural variables.
In topical cosmetic formulations, five subclasses are most commonly encountered:
| INCI Name | Former Name | Relative Abundance | Structural Role |
|---|---|---|---|
| Ceramide NP | Ceramide 3 | Most abundant | Core lamellar bilayer formation; primary contributor to overall barrier lipid mass |
| Ceramide NS | Ceramide 2 | Second most abundant | Broad lamellar organisation; complements NP in structural bilayer architecture |
| Ceramide AP | Ceramide 7 | Moderate | Alpha-hydroxy fatty acid variant; contributes to lamellar packing geometry and water-binding capacity |
| Ceramide EOP | Ceramide 1 | Lower — but critical | Unique long ω-esterified linoleic acid chain bridges adjacent lamellar bilayers; plays a uniquely important structural role; documented at reduced levels in published studies of skin experiencing barrier disruption |
| Ceramide NG | Ceramide 6-II (partial) | Moderate | Phytosphingosine-based; contributes to barrier lipid organisation; commonly sourced from plant-derived (phytoceramide) preparations |
Ceramide NP occupies a single bilayer plane. Ceramide EOP's ω-esterified linoleic acid extension spans into the adjacent bilayer, physically linking the lamellar stack. This is why reduced EOP levels are specifically associated with disrupted barrier architecture in published research.
A note on phytoceramides
Phytoceramides are plant-derived sphingolipids — most commonly extracted from wheat, rice bran, sweet potato, or konjac — that are structurally analogous to human ceramides. They are not structurally identical to human ceramide subclasses, but they are processed by skin enzymes into ceramide-like molecules. Published research documents their association with improved skin hydration and barrier parameters in studied populations, and they are widely used in formulations marketed as vegan alternatives to bovine-derived ceramide sources. Biotechnology-derived synthetic identical ceramides — produced via fermentation or chemical synthesis to exact human ceramide structure — represent a third category with the highest structural precision.
Complete INCI to former number reference — all 12 subclasses
Many products — particularly those formulated before the INCI nomenclature revision — still list ceramides by their older numerical names (Ceramide 1, 2, 3, etc.). The table below maps every subclass across both systems, enabling direct label comparison.
| Current INCI Name | Former Number | Fatty Acid Headgroup | Sphingoid Base | Notes |
|---|---|---|---|---|
| Ceramide EOP | Ceramide 1 | Esterified ω-hydroxy | Sphingosine | Structurally critical — bridges adjacent lamellar bilayers via linoleic acid ester chain |
| Ceramide NS | Ceramide 2 | Non-hydroxy | Sphingosine | Second most abundant; broad lamellar organisation |
| Ceramide NP | Ceramide 3 | Non-hydroxy | Phytosphingosine | Most abundant ceramide in human stratum corneum; primary barrier lipid |
| Ceramide EOH | Ceramide 4 | Esterified ω-hydroxy | 6-hydroxysphingosine | Esterified subclass; present in moderate amounts |
| Ceramide AS | Ceramide 5 | Alpha-hydroxy | Sphingosine | Alpha-hydroxy variant; contributes to lamellar packing |
| Ceramide NH | Ceramide 6-I | Non-hydroxy | 6-hydroxysphingosine | Hydroxysphingosine-based; contributes to bilayer structure |
| Ceramide AP | Ceramide 7 / 6-II | Alpha-hydroxy | Phytosphingosine | Commonly used in topical formulations; supports lamellar water-binding |
| Ceramide AH | Ceramide 8 | Alpha-hydroxy | 6-hydroxysphingosine | Less abundant; alpha-hydroxy hydroxysphingosine variant |
| Ceramide EOS | Ceramide 9 | Esterified ω-hydroxy | Sphingosine | Esterified class; structural role in lamellar organisation |
| Ceramide NDS | Ceramide 10 | Non-hydroxy | Dihydrosphingosine | Dihydrosphingosine-based; present in lower concentrations |
| Ceramide NG | Ceramide 6-II (partial) | Non-hydroxy | Phytosphingosine | Commonly sourced from phytoceramide preparations; widely used in topical formulations |
| Ceramide NOS | — | Non-hydroxy | Sphingosine (dihydro variant) | Less characterised in topical literature; present in stratum corneum at low levels |
If a product lists "Ceramide 3" it is referring to Ceramide NP — the most abundant subclass. "Ceramide 1" is Ceramide EOP — the structurally critical bridging subclass. Products listing only a single ceramide number provide a narrower spectrum of barrier lipid coverage than those listing multiple INCI-named subclasses.
Pseudo-ceramides — what they are and how they differ
Pseudo-ceramides are a distinct category: synthetic molecules designed to functionally mimic ceramide behaviour without possessing the exact sphingolipid structure of human ceramides. They are not ceramides in the strict biochemical sense — they do not appear on the INCI ceramide list and are not processed via the same enzymatic pathways. Common examples include Hydroxypropyl Biscetearyl Dimonium Chloride and certain lauroyl amino acid derivatives.
| Property | True Ceramides (INCI) | Pseudo-Ceramides | Phytoceramides |
|---|---|---|---|
| Structural identity to human ceramides | Identical (synthetic identical) or near-identical (natural-derived) | Not structurally identical — functional analog only | Analogous — not identical; processed enzymatically in skin |
| Enzymatic processing in skin | Not required — directly incorporates into lipid matrix | Not applicable — different metabolic pathway | Requires enzymatic conversion |
| Published barrier evidence depth | Extensive — multiple RCTs and mechanistic studies | More limited — primarily surface-feel and short-term hydration data | Moderate — hydration and TEWL studies available |
| Vegan-suitable | Depends on source (bovine-derived vs fermentation-derived vs plant) | Typically yes — synthetically produced | Yes — plant origin |
| Appears on INCI ceramide list? | Yes — Ceramide NP, AP, EOP, NS, etc. | No — listed under separate INCI names | Sometimes — depends on processing and final structure |
Look for INCI ceramide names specifically. "Ceramide NP", "Ceramide AP", "Ceramide EOP", "Ceramide NS" — these are the gold standard entries. Products listing multiple subclasses provide broader barrier lipid coverage than those listing a single type.
Older numerical names are still valid. "Ceramide 3" = Ceramide NP. "Ceramide 1" = Ceramide EOP. "Ceramide 6-II" ≈ Ceramide AP/NG. Use the conversion table above if you encounter numbered labels on existing products.
Position in the ingredient list matters. Ceramides listed in the upper-to-middle third of an ingredient list are present in meaningful concentrations. Ceramides appearing at the very bottom — after preservatives — are present at trace levels with limited functional relevance.
Prioritise Ceramide NP and Ceramide EOP together. Ceramide NP (formerly Ceramide 3) provides barrier lipid volume — it is the most abundant subclass and the structural backbone of the lamellar bilayer. Ceramide EOP (formerly Ceramide 1) provides architectural precision — its ω-esterified linoleic acid chain is the only ceramide subclass that bridges adjacent lamellar bilayers. A formulation containing both covers volume and architecture. A formulation containing NP without EOP is structurally incomplete. Ceramide NS (formerly Ceramide 2) and Ceramide AP (formerly Ceramide 7) are the next priority additions for broader spectrum coverage.
Look for the three-component system — and check the fatty acid specifically. Among the most clinically supported ceramide formulations include ceramides alongside cholesterol and a free fatty acid. The fatty acid fraction is not interchangeable: linoleic acid (C18:2) is the specific fatty acid documented to support optimal lamellar organisation — oleic acid or lauric acid do not replicate the same architecture. On labels, linoleic acid may appear as Linoleic Acid, Linoleoyl Lysophosphatidylcholine, or as part of a plant oil high in linoleic acid (rosehip, evening primrose). Palmitic acid (C16:0) and stearic acid (C18:0) complement the fatty acid fraction. A ceramide-only product without cholesterol and linoleic-acid-containing fatty acids provides a narrower barrier benefit than a formulation designed around the full equimolar ratio.
Why Ceramide Levels Fall — Depletion Triggers
Ceramide depletion is not an unusual event. It is a normal response to a range of common exposures — and understanding the triggers is as important as understanding the ingredient itself.
| Trigger | Mechanism | Evidence Strength |
|---|---|---|
| Ageing | Reduced lamellar body production and enzymatic processing efficiency; ceramide content documented as declining progressively from the third decade onwards | Strong — extensively documented |
| Harsh surfactants / over-cleansing | Anionic surfactants solubilise and remove intercellular lipids during cleansing; repeated exposure disrupts lamellar architecture | Strong — measurable TEWL increase documented post-exposure |
| UV radiation | UVB activates sphingomyelinase, generating ceramide fragments; chronic exposure alters ceramide subclass ratios in the stratum corneum | Strong |
| Low humidity / cold, dry environments | Environmental stress accelerates water loss, triggering barrier disruption signals that alter lipid synthesis rate | Moderate |
| Retinoids / exfoliating acids | Accelerated cell turnover can outpace lamellar body ceramide production in the maturing stratum granulosum, transiently reducing barrier lipid density | Moderate |
| Skin associated with barrier impairment | Reduced Ceramide EOP levels documented; disrupted lamellar organisation consistent across published biopsy and tape-strip studies | Strong — specifically Ceramide EOP and NP deficiency |
Ceramide depletion is not a cosmetic concern exclusive to ageing or dry skin. It is a predictable response to common daily exposures — cleansing, UV, environmental dryness, and the use of active ingredients that accelerate skin cell turnover. Any routine that includes retinoids, exfoliating acids, or frequent cleansing benefits from ceramide support. This is why ceramides appear across virtually every skin type protocol in clinical literature — not just in dry skin formulations.
Ceramide Benefits for Skin
Barrier integrity support
● Strong EvidenceThe most extensively documented benefit of topical ceramides is their association with supporting the integrity of the skin barrier — specifically through replenishment of the intercellular lipid matrix. Published controlled studies document measurable reductions in TEWL following consistent application of ceramide-containing formulations, with effect sizes correlating to ceramide concentration and the presence of complementary barrier lipids.
Reduced transepidermal water loss (TEWL)
● Strong EvidenceTEWL is the primary objective measure of barrier function in clinical research. Multiple published studies document statistically significant TEWL reductions in subjects using ceramide-dominant formulations compared to vehicle controls. The effect is consistently stronger when ceramides are formulated in a three-component system with cholesterol and free fatty acids — a finding replicated across multiple research groups.
Improved skin hydration markers
● Strong EvidenceCorneometer measurements — which quantify stratum corneum water content — consistently improve in published studies of ceramide-containing moisturisers. The mechanism is indirect: ceramides do not attract water themselves. They improve the structural integrity that prevents water from escaping, so skin retains more of whatever water is present.
Calming visible redness and discomfort
● Moderate EvidenceA functionally intact barrier reduces the ingress of environmental irritants that trigger visible redness and skin sensitivity. Published research documents improved skin comfort scores in subjects using ceramide-containing formulations — particularly in populations using potent actives or with skin associated with reactive presentations. The mechanism is indirect: improved barrier integrity rather than direct calming activity.
Tolerance of active ingredients
● Moderate EvidenceSeveral published studies and clinical protocols document that ceramide-containing moisturisers improve skin tolerability of retinoids and exfoliating acids — supporting tolerability in active ingredient routines. This finding has practical significance for routines incorporating potent actives.
Can Ceramides Support Skin Barrier Function?
Yes — and this is the most replicated finding in ceramide research. The mechanism is direct and anatomically specific: ceramides replenish the intercellular lipid matrix that physically restricts transepidermal water loss.
The most important formulation insight from the published literature is the three-component lipid system. Research groups including Mao-Qiang et al. (1996) and subsequent investigators demonstrated that barrier recovery in disrupted skin was significantly faster with a three-component system — ceramides, cholesterol, and free fatty acids — than with any single lipid alone. When ceramides were applied in isolation, barrier recovery was delayed. When the equimolar ratio approximating natural stratum corneum composition was applied, recovery was maximised. This is not a theoretical finding; it is among the most replicated results in barrier biology.
Topical ceramides replenish the intercellular lipid matrix directly — an exogenous delivery approach. Panthenol supports ceramide synthesis endogenously via the Vitamin B5 → Coenzyme A pathway, feeding the skin's own lipid production. Both approaches are documented in published research. Used together, they address barrier lipid support from two independent directions — direct replenishment and metabolic substrate support.
Ceramides by Skin Type
| Skin Type | Suitability | Primary Benefit | Best Used With |
|---|---|---|---|
| Dry / very dry | Excellent | Direct barrier lipid replenishment; reduced TEWL; improved moisture retention | Sodium Hyaluronate, Panthenol, cholesterol |
| Combination | Excellent | Barrier support in dry zones; lightweight formulations avoid heaviness in oily zones | Niacinamide, Sodium Hyaluronate |
| Oily / acne-prone | Well-tolerated | Not associated with pore congestion; improves barrier resilience without heaviness when formulated correctly | Niacinamide, lightweight humectants |
| Sensitive / reactive | Highly suitable | Barrier support reduces irritant ingress and associated visible redness; improves skin comfort with active ingredient use | Panthenol, Betaine, allantoin |
| Mature skin | Highly suitable | Addresses age-related ceramide depletion; supports structural barrier integrity alongside collagen-focused actives | Peptides, Sodium Hyaluronate, Panthenol |
| Post-active / post-procedure | Highly recommended | Directly addresses retinoid- and acid-induced transient barrier disruption; supports recovery of lamellar architecture | Panthenol, allantoin |
Ceramides vs Other Barrier Ingredients — What Is the Difference?
Ceramides are often compared to hyaluronic acid and niacinamide in the context of hydration and barrier support. Understanding how they differ — and why they are used together — is fundamental to building an effective routine.
| Property | Ceramides | Hyaluronic Acid | Niacinamide |
|---|---|---|---|
| Ingredient class | Sphingolipid — structural barrier lipid | Glycosaminoglycan — humectant | Vitamin B3 — multifunctional active |
| Primary hydration mechanism | Barrier integrity — prevents water from escaping | Humectancy — attracts water to the surface | Barrier lipid synthesis support (indirect); sebum regulation |
| Direct water attraction? | No | Yes — up to 1,000× its weight | No direct humectant activity |
| Barrier lipid replenishment? | Yes — directly | No | Indirectly — associated with stimulating ceramide synthesis in keratinocytes in studied models |
| TEWL reduction? | Yes — documented in published studies | Mild surface occlusion at high MW only | Yes — associated in multiple published studies |
| Best used together? | Yes — complementary mechanisms address different aspects of barrier and hydration. Ceramides + HA + Niacinamide is one of the most evidence-supported combinations in barrier-focused skincare. | ||
Ceramides and hyaluronic acid address the same end goal — keeping skin hydrated — through opposite mechanisms. HA attracts water in. Ceramides prevent water from getting out. Niacinamide supports the skin's own ceramide synthesis, making it a metabolic complement to direct ceramide delivery. None of these ingredients replaces the others; all three address a genuinely different part of the skin's hydration architecture.
How to Use Ceramides in a Skincare Routine
Harsh anionic surfactants solubilise the very intercellular lipids ceramides are designed to replenish. A low-surfactant or amino acid-based cleanser preserves baseline ceramide levels so the topical step is rebuilding rather than compensating.
If using serums with sodium hyaluronate, niacinamide, or peptides, apply these before your ceramide moisturiser. Water-based layers before lipid-based layers — ceramide delivery vehicles are typically emulsions or richer creams that form a semi-occlusive film.
Applying to slightly damp skin traps surface moisture and allows any humectant components in the formula to draw additional water into the stratum corneum before the ceramide film forms. This maximises the hydration retained by the barrier lipid layer.
Ceramide application is particularly important after retinoids or exfoliating acids — both of which transiently disrupt lamellar architecture. Apply ceramide moisturiser immediately after active ingredients in the evening routine, or choose a ceramide-based moisturiser to layer over actives. The skin's overnight recovery processes also align with ceramide replenishment.
Unlike humectants that provide an immediate effect on skin feel, ceramide barrier support builds with consistent use. Published studies measuring TEWL outcomes typically show statistically significant improvements within 4–8 weeks of daily application. Morning and evening use is documented in clinical protocols.
What to Combine Ceramides With
- Cholesterol + free fatty acids — the most clinically important combination. The published evidence for the three-component lipid system (ceramides + cholesterol + fatty acids in approximately equimolar ratios) is stronger than for ceramides alone. Formulations that include all three are documented to support barrier recovery more effectively in studied models.
- Sodium Hyaluronate — HA attracts water; ceramides prevent it from escaping. The combination addresses both sides of the skin hydration equation — water attraction and water retention.
- Niacinamide — associated with stimulating ceramide synthesis in keratinocytes in studied models; complements direct ceramide delivery with endogenous synthesis support.
- Panthenol (Provitamin B5) — supports ceramide synthesis via the Vitamin B5 → Coenzyme A pathway; an endogenous metabolic complement to exogenous ceramide replenishment.
- Betaine — osmolyte that supports cellular water balance within the epidermis; complements ceramide barrier support at the cellular level.
- Retinoids / AHAs / BHAs — not a combination ingredient, but ceramides are specifically indicated as a complementary moisturiser for routines incorporating these actives due to their role in supporting barrier integrity during periods of increased cell turnover.
Side Effects of Ceramides — Are They Safe?
Ceramides have an established safety profile across decades of cosmetic use and multiple regulatory reviews. As biomimetic lipids — structurally consistent with the skin's own intercellular matrix — they are among the most well-tolerated ingredient categories in dermatological formulation.
| Concern | Reality |
|---|---|
| Irritation | Rare at cosmetic concentrations. Ceramides are generally regarded as non-irritating in the reviewed literature. If irritation occurs in a ceramide-containing product, investigation of other formula components is indicated. |
| Allergic reaction | Rare. Patch testing recommended as standard before any new product. Wheat-derived phytoceramide products may carry a consideration for individuals with documented wheat sensitivity — consult a qualified dermatologist. |
| Comedogenicity (pore clogging) | Ceramides are not associated with pore congestion in published assessments. Heaviness or congestion from ceramide-containing products is typically attributable to occlusive co-formulants rather than ceramides themselves. |
| Photosensitivity | None documented — safe for morning use without additional photosensitivity risk. |
| Pregnancy | Generally considered safe — ceramides are biomimetic lipids with no documented systemic absorption concern. As with any new active during pregnancy, consult your healthcare provider. |
| Drug interactions | No known interactions at cosmetic concentrations. |
Ceramide INCI names — Ceramide NP, Ceramide AP, Ceramide EOP, Ceramide NS, and others — appear in the EU cosmetic ingredient database (CosIng) and are permitted ingredients under Regulation (EC) No 1223/2009. They are similarly unrestricted in US FDA cosmetic categories, India CDSCO cosmetic framework, and the ASEAN Cosmetic Directive. No restrictions or usage limits apply at standard cosmetic concentrations.
Frequently Asked Questions
- Elias, P.M. (1983). Epidermal lipids, barrier function, and desquamation. Journal of Investigative Dermatology, 80(Suppl), 44s–49s.
- Mao-Qiang, M., Feingold, K.R., & Elias, P.M. (1993). Inhibition of cholesterol and sphingolipid synthesis causes paradoxical effects on permeability barrier homeostasis. Journal of Investigative Dermatology, 101(2), 185–190.
- Mao-Qiang, M., et al. (1996). Exogenous nonphysiologic vs physiologic lipids — divergent mechanisms for correction of permeability barrier dysfunction. Archives of Dermatology, 132(8), 945–951.
- Coderch, L., et al. (2003). Ceramides and skin function. American Journal of Clinical Dermatology, 4(2), 107–129.
- Proksch, E., Brandner, J.M., & Jensen, J.M. (2008). The skin: an indispensable barrier. Experimental Dermatology, 17(12), 1063–1072.
- Lynde, C.W., et al. (2014). Moisturizers and ceramide-containing moisturizers may offer concomitant therapy with benefits. Journal of Clinical and Aesthetic Dermatology, 7(3), 18–26.
- Choi, M.J., & Maibach, H.I. (2005). Role of ceramides in barrier function of healthy and diseased skin. American Journal of Clinical Dermatology, 6(4), 215–223.
- van Smeden, J., et al. (2014). The important role of stratum corneum lipids for the cutaneous barrier function. Biochimica et Biophysica Acta, 1841(3), 295–313.
© 2026 Boldpurity · For educational purposes only · Not to be reproduced without permission.
